• Could This GLP-1 RA be Right for Your Adult Patients With T2D?

  • Jun 6 2022
  • Length: 24 mins
  • Podcast

Could This GLP-1 RA be Right for Your Adult Patients With T2D?

  • Summary

  • Join leaders in the field of diabetes Dr. Jim Gavin, Dr. Pablo Mora, and Dr. Bob Busch as they navigate through a clinical study. What do you need to know about using a GLP-1 RA for glycemic control with patients who have T2D? Are there any considerations for specific populations such as those who have moderate renal impairment?

    This program is intended for clinicians. The information presented is aligned with the views and opinions of the speakers and is sponsored by Novo Nordisk. This podcast is not to be used as medical advice and is intended for educational purposes only.

    Faculty Presenters:  

    James R. Gavin III, MD, PhD
    Clinical Professor of Medicine, Emory University
    Chief Medical Officer, Healing Our Village, Inc.
    Atlanta, Georgia

    Robert Busch, MD
    Director of Clinical Research
    Albany Med Faculty Practice, Community Endocrine Group
    Albany, New York  

    Pablo F. Mora, MD, FACE, MSc, CDCES
    Endocrinologist, North Texas Diabetes & Endocrinology
    Clinical Professor, Division of Endocrinology at University of Texas Southwestern Medical Center
    Dallas, Texas

    Show More Show Less
activate_samplebutton_t1

What listeners say about Could This GLP-1 RA be Right for Your Adult Patients With T2D?

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.